{"disease":{"id":"locally-advanced-or-metastatic-and-unresectable-hcc","name":"locally advanced or metastatic and unresectable hcc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03764293","title":"A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":543,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}